Panel Discussion | Innovations in the Cath Lab

Sunday, March 8, 2026

4:20 PM - 4:40 PM EST

Location: International Ballroom West

Moderator(s)

Sam Chitsaz, MD, FACC, FSCAI

Interventional Cardiologist
Sutter Health

Disclosure(s): No financial relationships to disclose
Nichelle Megowan, MD

Assistant Professor, David Geffen School of Medicine - UCLA Interventional Cardiology
Harbor UCLA Medical Center

Disclosure(s): No financial relationships to disclose
John P. Reilly, MD

Chief of Cardiology
Stony Brook Southampton Hospital
Stony Brook, New York, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Takashi Akasaka, MD, PhD

Senior Consultant
Nishinomiya Watanabe Cardiovascular Cerebral Center
Nishinomiya, Hyogo, Japan

Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 18, 2025)
Tim A. Fischell, MD, FACC, MSCAI

Director of Cardiovascular Research
Borgesd Heart Institute
Kalamazoo, Michigan, United States

Disclosure(s): Balosmark, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); VivaCath, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)
Ryan D. Madder, MD

Program Director, Interventional Cardiology Fellowship
Corewell Health East/William Beaumont University Hospital
Northville, Michigan, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus Vascular Robotics: Consulting Fees (e.g., advisory boards) (Terminated), Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Orchestra Biomed: Consulting Fees (e.g., advisory boards) (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing)
Jean-Michel Paradis, MD

Structural and Interventional Cardiologist
Quebec Heart and Lung Institute
Quebec, Quebec, Canada

Disclosure(s): No financial relationships to disclose
Venkatesh Ramaiah, MD, FACS

Co Founder and Chief PULSE CARDIOVASCULAR INSTITUTE CHAIRMAN TEDCONGRESS CONSULTANT ARIZONA HEART INSTITUTE OSBORN MEDICAL CENTER
Pulse Cardiovascular Institute
Scottsdale, Arizona, United States

Disclosure information not submitted.

Disclosure(s):

Sam Chitsaz, MD, FACC, FSCAI: No financial relationships to disclose

Nichelle Megowan, MD: No financial relationships to disclose

John P. Reilly, MD: No financial relationships to disclose

Takashi Akasaka, MD, PhD: Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 18, 2025)

Tim A. Fischell, MD, FACC, MSCAI: Balosmark, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); VivaCath, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)

Ryan D. Madder, MD: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus Vascular Robotics: Consulting Fees (e.g., advisory boards) (Terminated), Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Orchestra Biomed: Consulting Fees (e.g., advisory boards) (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing)

Jean-Michel Paradis, MD: No financial relationships to disclose